肿瘤免疫治疗多组学数据分析

肿瘤免疫治疗多组学数据分析通过整合转录组、肿瘤突变负荷、PDL1表达、体细胞突变谱及微卫星不稳定等多维数据，突破单一生物标志物的预测局限，构建免疫治疗反应精准预测模型。支持个体化疗效评估、耐药机制解析，为临床决策优化、新型生物标志物发掘和联合治疗方案设计提供科学依据，推动肿瘤免疫精准治疗发展，最终改善患者生存获益。Multi-omics data analysis for cancer immunotherapy integrates multi-dimensional data including transcriptome, tumor mutation burden (TMB), PD-L1 expression, somatic mutation profile, and microsatellite instability (MSI) to overcome the predictive limitations of single biomarkers, and develops precise predictive models for immunotherapy response. This approach enables individualized efficacy evaluation, elucidation of drug resistance mechanisms, provides scientific evidence for optimizing clinical decision-making, discovering novel biomarkers, and designing combination therapy regimens, promotes the advancement of precision cancer immunotherapy, and ultimately improves patient survival outcomes.

搜集汇总

背景与挑战

背景概述

该数据集整合了转录组、肿瘤突变负荷、PDL1表达等多维数据，构建了免疫治疗反应预测模型，旨在优化临床决策和发掘新型生物标志物，推动肿瘤免疫精准治疗发展。